These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15780438)

  • 1. Role of IgA in the defense against respiratory infections IgA deficient mice exhibited increased susceptibility to intranasal infection with Mycobacterium bovis BCG.
    Rodríguez A; Tjärnlund A; Ivanji J; Singh M; García I; Williams A; Marsh PD; Troye-Blomberg M; Fernández C
    Vaccine; 2005 Apr; 23(20):2565-72. PubMed ID: 15780438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric IgR knockout mice are more susceptible to mycobacterial infections in the respiratory tract than wild-type mice.
    Tjärnlund A; Rodríguez A; Cardona PJ; Guirado E; Ivanyi J; Singh M; Troye-Blomberg M; Fernández C
    Int Immunol; 2006 May; 18(5):807-16. PubMed ID: 16569672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
    Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis.
    Hope JC; Thom ML; Villarreal-Ramos B; Vordermeier HM; Hewinson RG; Howard CJ
    Clin Exp Immunol; 2005 Jan; 139(1):48-56. PubMed ID: 15606613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin A and CD8 T-cell mucosal immune defenses protect against intranasal infection with Chlamydia pneumoniae.
    Rodríguez A; Rottenberg M; Tjärnlund A; Fernández C
    Scand J Immunol; 2006 Mar; 63(3):177-83. PubMed ID: 16499570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection.
    Skelding KA; Hickey DK; Horvat JC; Bao S; Roberts KG; Finnie JM; Hansbro PM; Beagley KW
    Vaccine; 2006 Jan; 24(3):355-66. PubMed ID: 16153755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response induced by recombinant Mycobacterium bovis BCG producing the cholera toxin B subunit.
    Biet F; Kremer L; Wolowczuk I; Delacre M; Locht C
    Infect Immun; 2003 May; 71(5):2933-7. PubMed ID: 12704173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinant role for Toll-like receptor signalling in acute mycobacterial infection in the respiratory tract.
    Tjärnlund A; Guirado E; Julián E; Cardona PJ; Fernández C
    Microbes Infect; 2006 Jun; 8(7):1790-800. PubMed ID: 16815067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against bovine tuberculosis induced by oral vaccination of cattle with Mycobacterium bovis BCG is not enhanced by co-administration of mycobacterial protein vaccines.
    Wedlock DN; Aldwell FE; Vordermeier HM; Hewinson RG; Buddle BM
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):220-7. PubMed ID: 22005585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice.
    Liu S; Gong Q; Wang C; Liu H; Wang Y; Guo S; Wang W; Liu J; Shao M; Chi L; Zhao K; Wang Z; Shi Y; Huang Y; Guli A; Zhang C; Kong X
    Immunol Lett; 2008 May; 117(2):136-45. PubMed ID: 18339431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
    Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
    Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission of IgA and IgG monoclonal antibodies to mucosal fluids following intranasal or parenteral delivery.
    Falero-Diaz G; Challacombe S; Rahman D; Mistry M; Douce G; Dougan G; Acosta A; Ivanyi J
    Int Arch Allergy Immunol; 2000 Jun; 122(2):143-50. PubMed ID: 10878493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combined DNA vaccine provides protective immunity against Mycobacterium bovis and Brucella abortus in cattle.
    Hu XD; Yu DH; Chen ST; Li SX; Cai H
    DNA Cell Biol; 2009 Apr; 28(4):191-9. PubMed ID: 19364278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of immunological markers in the respiratory tract but not in serum correlate with active pulmonary mycobacterial infection in mice.
    Arko-Mensah J; Rahman MJ; Julián E; Horner G; Singh M; Fernández C
    Clin Microbiol Infect; 2009 Aug; 15(8):777-86. PubMed ID: 19392884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgA modulates respiratory dysfunction as a sequela to pulmonary chlamydial infection as neonates.
    Lanka GK; Yu JJ; Gong S; Gupta R; Mustafa SB; Murthy AK; Zhong G; Chambers JP; Guentzel MN; Arulanandam BP
    Pathog Dis; 2016 Apr; 74(3):. PubMed ID: 26755533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium bovis Δmce2 double deletion mutant protects cattle against challenge with virulent M. bovis.
    Blanco FC; Bianco MV; Garbaccio S; Meikle V; Gravisaco MJ; Montenegro V; Alfonseca E; Singh M; Barandiaran S; Canal A; Vagnoni L; Buddle BM; Bigi F; Cataldi A
    Tuberculosis (Edinb); 2013 May; 93(3):363-72. PubMed ID: 23518075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination of cattle with Mycobacterium bovis BCG by a combination of systemic and oral routes.
    Buddle BM; Denis M; Aldwell FE; Martin Vordermeier H; Glyn Hewinson R; Neil Wedlock D
    Tuberculosis (Edinb); 2008 Nov; 88(6):595-600. PubMed ID: 18439875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with Single Oral Dose of Alginate-Encapsulated BCG Elicits Effective and Long-Lasting Mucosal Immune Responses.
    Hosseini M; Dobakhti F; Pakzad SR; Ajdary S
    Scand J Immunol; 2015 Dec; 82(6):489-97. PubMed ID: 26286252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis.
    Andersen CS; Dietrich J; Agger EM; Lycke NY; Lövgren K; Andersen P
    Infect Immun; 2007 Jan; 75(1):408-16. PubMed ID: 17074845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.